News Article

Imbio announces $1.5 million financing
Author: Imbio LLC
Source: Company Data ( click here to go to the source)

Featured firm in this article: Imbio LLC of Minneapolis, MN

Imbio announces $1.5 million financing

Funds PRM Lung, CT Imaging Biomarker for COPD

Minneapolis, MN. — Imbio, LLC, a medical imaging software company, has closed on $1.5 million

in Series A financing. Existing investor Invenshure, LLC, led the round with additional funding from

several angel investors. The proceeds will support the commercialization of Imbio's proprietary

Parametric Response Mapping (PRM) technology used to detect, characterize and quantify

abnormal tissue in computed tomography (CT), magnetic resonance imaging (MRI) and positron

emission tomography (PET) images.

"We appreciate the continued support of our investors as we move closer to launching the first

application of our PRM technology, PRM LUNG," said Troy Kopischke, President and Chief

Operating Officer of Imbio. "PRM LUNG is designed to significantly improve the diagnostic power

of CT scans in chronic obstructive pulmonary disease (COPD), a progressive condition that is the

third leading cause of death in the U.S."

Danny Cunagin, co-founder of Invenshure, commented, "We are pleased to support this

breakthrough technology. PRM LUNG has the potential to be the first imaging software to

distinguish between the sub-types of COPD, helping physicians personalize treatment for patients."

About Imbio, LLC

Imbio, LLC, is a medical imaging company founded to commercialize quantitative imaging

biomarkers developed by leading universities and research institutions. Imaging biomarkers are

key drivers of personalized medicine, which is rapidly evolving due to "big data" availability in cloud

databases. Imbio is developing and licensing several imaging biomarkers that will be added to the

company's growing imaging/processing cloud platform. For more information, visit

About Invenshure, LLC

Formed in 2011 by seasoned serial entrepreneurs Danny Cunagin and Troy Kopischke, Invenshure

combines a technology incubator (Invenshure, LLC) and a fund (Invenshure Fund I) to launch and

grow technology-based companies. The principals at Invenshure search industry and universities,

commercializing novel medical informatics, therapeutic and platform technologies in the rapidly

evolving healthcare marketplace. Find out more at